Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Forbes

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Gastroenterology|October 23, 2025
Retraction Notice to: "CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure" Gastroenterology 2015;149:1896-1909.e14Benjamin M Stutchfield, Daniel J Antoine, Alison C Mackinnon, et al.
Journal of Hepatology|November 22, 2020
TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progressionBenjamin J Dwyer, Edward J Jarman, Jully Gogoi-Tiwari, et al.
Gastroenterology|September 8, 2015
CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver FailureBenjamin M Stutchfield, Daniel J Antoine, Alison C Mackinnon, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Nature Medicine|January 10, 2025
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trialPaul N Brennan, Mark MacMillan, Thomas Manship, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2020
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytesEleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, et al.
BMJ Open|December 9, 2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UKChristopher Humphries, Melisande Addison, Guruprasad Aithal, et al.
Hepatology (Baltimore, Md.)|March 31, 2020
Regional Differences in Human Biliary Tissues and Corresponding In Vitro-Derived OrganoidsCasey A Rimland, Samantha G Tilson, Carola M Morell, et al.
Hepatology (Baltimore, Md.)|April 19, 2021
Pharmacological Activation of Nrf2 Enhances Functional Liver RegenerationBenjamin K Y Chan, Mohamed Elmasry, Shiva S Forootan, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Gastroenterology|October 23, 2025
Retraction Notice to: "CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure" Gastroenterology 2015;149:1896-1909.e14Benjamin M Stutchfield, Daniel J Antoine, Alison C Mackinnon, et al.
Journal of Hepatology|November 22, 2020
TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progressionBenjamin J Dwyer, Edward J Jarman, Jully Gogoi-Tiwari, et al.
Gastroenterology|September 8, 2015
CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver FailureBenjamin M Stutchfield, Daniel J Antoine, Alison C Mackinnon, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Nature Medicine|January 10, 2025
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trialPaul N Brennan, Mark MacMillan, Thomas Manship, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2020
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytesEleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, et al.
BMJ Open|December 9, 2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UKChristopher Humphries, Melisande Addison, Guruprasad Aithal, et al.
Hepatology (Baltimore, Md.)|March 31, 2020
Regional Differences in Human Biliary Tissues and Corresponding In Vitro-Derived OrganoidsCasey A Rimland, Samantha G Tilson, Carola M Morell, et al.
Hepatology (Baltimore, Md.)|April 19, 2021
Pharmacological Activation of Nrf2 Enhances Functional Liver RegenerationBenjamin K Y Chan, Mohamed Elmasry, Shiva S Forootan, et al.
Pageof 17